These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 25782469)

  • 21. Evaluation of the safety, pharmacodynamic, and pharmacokinetic effects following oral coadministration of immediate-release morphine with ethanol in healthy male participants.
    Setnik B; Sokolowska M; Johnson F; Oldenhof J; Romach M
    Hum Psychopharmacol; 2014 May; 29(3):251-65. PubMed ID: 24911576
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sodium oxybate: new drug. Fewer attacks of cataplexy in some patients.
    Prescrire Int; 2007 Jun; 16(89):98-101. PubMed ID: 17582923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gamma-hydroxybutyrate and ethanol effects and interactions in humans.
    Thai D; Dyer JE; Benowitz NL; Haller CA
    J Clin Psychopharmacol; 2006 Oct; 26(5):524-9. PubMed ID: 16974199
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Sodium oxybate relieves pain and improves function in fibromyalgia syndrome: a randomized, double-blind, placebo-controlled, multicenter clinical trial.
    Russell IJ; Perkins AT; Michalek JE;
    Arthritis Rheum; 2009 Jan; 60(1):299-309. PubMed ID: 19116896
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers.
    Dumont GJ; Schoemaker RC; Touw DJ; Sweep FC; Buitelaar JK; van Gerven JM; Verkes RJ
    J Psychopharmacol; 2010 Feb; 24(2):155-64. PubMed ID: 19164498
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the cognitive, psychomotor and pharmacokinetic profiles of rupatadine, hydroxyzine and cetirizine, in combination with alcohol, in healthy volunteers.
    Barbanoj MJ; García-Gea C; Antonijoan R; Izquierdo I; Donado E; Pérez I; Solans A; Jané F
    Hum Psychopharmacol; 2006 Jan; 21(1):13-26. PubMed ID: 16389668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Central nervous system effects of the interaction between risperidone (single dose) and the 5-HT6 antagonist SB742457 (repeated doses) in healthy men.
    Liem-Moolenaar M; Rad M; Zamuner S; Cohen AF; Lemme F; Franson KL; van Gerven JM; Pich EM
    Br J Clin Pharmacol; 2011 Jun; 71(6):907-16. PubMed ID: 21223356
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dual orexin receptor antagonism by almorexant does not potentiate impairing effects of alcohol in humans.
    Hoch M; Hay JL; Hoever P; de Kam ML; te Beek ET; van Gerven JM; Dingemanse J
    Eur Neuropsychopharmacol; 2013 Feb; 23(2):107-17. PubMed ID: 22658401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Novel Δ(9) -tetrahydrocannabinol formulation Namisol® has beneficial pharmacokinetics and promising pharmacodynamic effects.
    Klumpers LE; Beumer TL; van Hasselt JG; Lipplaa A; Karger LB; Kleinloog HD; Freijer JI; de Kam ML; van Gerven JM
    Br J Clin Pharmacol; 2012 Jul; 74(1):42-53. PubMed ID: 22680341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sodium oxybate in the treatment of alcohol dependence: from the alcohol withdrawal syndrome to the alcohol relapse prevention.
    Skala K; Caputo F; Mirijello A; Vassallo G; Antonelli M; Ferrulli A; Walter H; Lesch O; Addolorato G
    Expert Opin Pharmacother; 2014 Feb; 15(2):245-57. PubMed ID: 24283802
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 3,4-Methylenedioxymethamphetamine (ecstasy) and alcohol interactions in humans: psychomotor performance, subjective effects, and pharmacokinetics.
    Hernández-López C; Farré M; Roset PN; Menoyo E; Pizarro N; Ortuño J; Torrens M; Camí J; de La Torre R
    J Pharmacol Exp Ther; 2002 Jan; 300(1):236-44. PubMed ID: 11752122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sodium Oxybate for Alcohol Dependence: A Network Meta-Regression Analysis Considering Population Severity at Baseline and Treatment Duration.
    Guiraud J; Addolorato G; Aubin HJ; Bachelot S; Batel P; de Bejczy A; Benyamina A; Caputo F; Couderc M; Dematteis M; Goudriaan AE; Gual A; Lecoustey S; Lesch OM; Maremmani I; Nutt DJ; Paille F; Perney P; Rehm J; Rolland B; Scherrer B; Simon N; Söderpalm B; Somaini L; Sommer WH; Spanagel R; Walter H; van den Brink W
    Alcohol Alcohol; 2023 Mar; 58(2):125-133. PubMed ID: 36617267
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Interaction of Ethanol and Oral ANS-6637, a Selective ALDH2 Inhibitor in Males: A Randomized, Double-Blind, Placebo-Controlled, Single-Ascending Dose Cohort Study.
    O'Malley SS; Shram MJ; Levy-Cooperman N; Vince B; Strumph PM; Diamond I; Blackburn BK
    Alcohol Clin Exp Res; 2020 Sep; 44(9):1885-1895. PubMed ID: 32687612
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics and pharmacodynamics of γ-hydroxybutyrate in healthy subjects.
    Liechti ME; Quednow BB; Liakoni E; Dornbierer D; von Rotz R; Gachet MS; Gertsch J; Seifritz E; Bosch OG
    Br J Clin Pharmacol; 2016 May; 81(5):980-8. PubMed ID: 26659543
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Alcohol Administered With Flibanserin in Healthy Premenopausal Women: A Randomized, Double-Blind, Single-Dose Crossover Study.
    Simon JA; Clayton AH; Parish SJ; Apfel SC; Millheiser L
    J Sex Med; 2020 Jan; 17(1):83-93. PubMed ID: 31735618
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of paediatric narcolepsy with sodium oxybate: a double-blind, placebo-controlled, randomised-withdrawal multicentre study and open-label investigation.
    Plazzi G; Ruoff C; Lecendreux M; Dauvilliers Y; Rosen CL; Black J; Parvataneni R; Guinta D; Wang YG; Mignot E
    Lancet Child Adolesc Health; 2018 Jul; 2(7):483-494. PubMed ID: 30169321
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pharmacokinetic and pharmacodynamic interactions of bretazenil and diazepam with alcohol.
    van Steveninck AL; Gieschke R; Schoemaker RC; Roncari G; Tuk B; Pieters MS; Breimer DD; Cohen AF
    Br J Clin Pharmacol; 1996 Jun; 41(6):565-73. PubMed ID: 8799523
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Acute neuropsychological effects of MDMA and ethanol (co-)administration in healthy volunteers.
    Dumont GJ; Wezenberg E; Valkenberg MM; de Jong CA; Buitelaar JK; van Gerven JM; Verkes RJ
    Psychopharmacology (Berl); 2008 Apr; 197(3):465-74. PubMed ID: 18305926
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The influence of gender and food on the pharmacokinetics of sodium oxybate oral solution in healthy subjects.
    Borgen LA; Okerholm R; Morrison D; Lai A
    J Clin Pharmacol; 2003 Jan; 43(1):59-65. PubMed ID: 12520629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The nightly use of sodium oxybate is associated with a reduction in nocturnal sleep disruption: a double-blind, placebo-controlled study in patients with narcolepsy.
    Black J; Pardi D; Hornfeldt CS; Inhaber N
    J Clin Sleep Med; 2010 Dec; 6(6):596-602. PubMed ID: 21206549
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.